J2 Capital Management’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,070
Closed -$322K 119
2025
Q4
$322K Buy
4,070
+726
+22% +$56.9K 0.23% 103
2025
Q3
$267K Buy
3,344
+20
+0.6% +$1.71K 0.2% 109
2025
Q2
$302K Buy
3,324
+47
+1% +$4.29K 0.24% 97
2025
Q1
$307K Buy
3,277
+46
+1% +$4.12K 0.28% 78
2024
Q4
$294K Buy
+3,231
New +$308K 0.28% 92
2023
Q3
$234K Sell
3,296
-100
-3% -$7.48K 0.3% 88
2023
Q2
$262K Sell
3,396
-117
-3% -$9.06K 0.31% 88
2023
Q1
$264K Buy
3,513
+157
+5% +$11.7K 0.41% 70
2022
Q4
$264K Buy
3,356
+82
+3% +$6.15K 0.45% 65
2022
Q3
$230K Buy
3,274
+74
+2% +$5.8K 0.44% 62
2022
Q2
$256K Buy
+3,200
New +$250K 0.39% 63

Other funds holding CL

J2 Capital Management's CL Position: Q1 2026 in Review

J2 Capital Management sold out of Colgate-Palmolive (CL) in Q1 2026, closing a stake of 4,070 shares — an estimated $322K sold.

J2 Capital Management first reported a position in CL in Q2 2022 and held it in 11 quarters. The position peaked at $322K in Q4 2025. 1,948 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • J2 Capital Management reported no remaining Colgate-Palmolive position as of Q1 2026 after selling out during the quarter.
  • J2 Capital Management sold 4,070 Colgate-Palmolive shares in Q1 2026, an estimated $322K.
  • J2 Capital Management first reported a position in Colgate-Palmolive in Q2 2022 and held it in 11 quarters.
  • J2 Capital Management's Colgate-Palmolive position peaked at $322K in Q4 2025.
  • 1,948 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on J2 Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.